Non-neurogenic Male LUTS

The EAU 2026 non-neurogenic male LUTS / benign prostatic obstruction pathway — assess and phenotype bothersome male LUTS, then match watchful waiting, phenotype-driven drug therapy (with a nocturia branch) or size-stratified surgery, with follow-up tuned to the chosen modality. A separate lane, new in 2026, covers young men with primary bladder neck obstruction or dysfunctional voiding, where the obstruction is functional rather than prostatic. Standard options lead; select-case techniques are subordinated. Switch between the visual Pathway map and the phase-by-phase Explorer.